BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zamberletti E, Rubino T, Parolaro D. Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder. Pharmacol Ther 2021;226:107878. [PMID: 33895189 DOI: 10.1016/j.pharmthera.2021.107878] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang F, Jin T, Li H, Long H, Liu Y, Jin S, Lu Y, Peng Y, Liu C, Zhao L, Wang X. Cannabidivarin alleviates α-synuclein aggregation via DAF-16 in Caenorhabditis elegans. FASEB J 2023;37:e22735. [PMID: 36583706 DOI: 10.1096/fj.202200278RR] [Reference Citation Analysis]
2 Schiavi S, Manduca A, Carbone E, Buzzelli V, Rava A, Feo A, Ascone F, Morena M, Campolongo P, Hill MN, Trezza V. Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats. Neuropsychopharmacology 2022. [PMID: 36114286 DOI: 10.1038/s41386-022-01454-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Khalsa JH, Bunt G, Blum K, Maggirwar SB, Galanter M, Potenza MN. Review: Cannabinoids as Medicinals. Curr Addict Rep 2022;9:630-46. [PMID: 36093358 DOI: 10.1007/s40429-022-00438-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Khalsa JH, Bunt G, Blum K, Maggirwar SB, Galanter M, Potenza MN. Review: Cannabinoids as Medicinals. Curr Addict Rep. [DOI: 10.1007/s40429-022-00438-3] [Reference Citation Analysis]
5 Wang X, Lin C, Wu S, Zhang T, Wang Y, Jiang Y, Wang X. Cannabidivarin alleviates neuroinflammation by targeting TLR4 co-receptor MD2 and improves morphine-mediated analgesia. Front Immunol 2022;13:929222. [DOI: 10.3389/fimmu.2022.929222] [Reference Citation Analysis]
6 Caprioglio D, Amin HIM, Taglialatela-Scafati O, Muñoz E, Appendino G. Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research. Biomolecules 2022;12:1084. [PMID: 36008978 DOI: 10.3390/biom12081084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Santiago-Castañeda C, Huerta de la Cruz S, Martínez-Aguirre C, Orozco-Suárez SA, Rocha L. Cannabidiol Reduces Short- and Long-Term High Glutamate Release after Severe Traumatic Brain Injury and Improves Functional Recovery. Pharmaceutics 2022;14. [PMID: 36015236 DOI: 10.3390/pharmaceutics14081609] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Saad AK, Akour A, Mahboob A, Aburuz S, Sadek B. Role of Brain Modulators in Neurodevelopment: Focus on Autism Spectrum Disorder and Associated Comorbidities. Pharmaceuticals 2022;15:612. [DOI: 10.3390/ph15050612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Pagano C, Navarra G, Coppola L, Avilia G, Bifulco M, Laezza C. Cannabinoids: Therapeutic Use in Clinical Practice. IJMS 2022;23:3344. [DOI: 10.3390/ijms23063344] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
10 Mastellone G, Marengo A, Sgorbini B, Scaglia F, Capetti F, Gai F, Peiretti PG, Rubiolo P, Cagliero C. Characterization and Biological Activity of Fiber-Type Cannabis sativa L. Aerial Parts at Different Growth Stages. Plants (Basel) 2022;11:419. [PMID: 35161400 DOI: 10.3390/plants11030419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Miyabe Shields C, Kirk RD. Pharmaceutical Applications of Hemp. Revolutionizing the Potential of Hemp and Its Products in Changing the Global Economy 2022. [DOI: 10.1007/978-3-031-05144-9_5] [Reference Citation Analysis]
12 Mnekin L, Ripoll L. Topical Use of Cannabis sativa L. Biochemicals. Cosmetics 2021;8:85. [DOI: 10.3390/cosmetics8030085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]